Shah SC - Search Results

1

Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.

Parikh PM, Shah SR, Shah SC, Sheth V, Patel RA, Shah KC, Jain PK. Parikh PM, et al. Among authors: shah kc, shah sr, shah sc. Indian J Cancer. 1996 Mar;33(1):17-20. Indian J Cancer. 1996. PMID: 9063013 Clinical Trial.

2

"Pain clinics and advanced cancer" a review.

Shah SC. Shah SC. Indian J Cancer. 1969 Dec;6(4):275-82. Indian J Cancer. 1969. PMID: 5382963 No abstract available.

3

Multifocal bilateral breast masses in HIV-positive status.

Vaishnav K, Shah S, Pandhi S, Rathi Y. Vaishnav K, et al. Indian J Cancer. 2011 Apr-Jun;48(2):253-5. doi: 10.4103/0019-509X.82878. Indian J Cancer. 2011. PMID: 21768677 Free article. No abstract available.

4

Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry.

Shah S, Evans DG, Blair V, Burnell LD, Birch JM. Shah S, et al. Cancer. 1993 Aug 1;72(3):819-27. doi: 10.1002/1097-0142(19930801)72:3<819::aid-cncr2820720330>3.0.co;2-u. Cancer. 1993. PMID: 8334636

5

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites.

Hurteau J, Rodriguez GC, Whitaker RS, Shah S, Mills G, Bast RC, Berchuck A. Hurteau J, et al. Cancer. 1994 Jul 1;74(1):93-9. doi: 10.1002/1097-0142(19940701)74:1<93::aid-cncr2820740117>3.0.co;2-p. Cancer. 1994. PMID: 8004589

6

ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis.

Dellon ES, Muir AB, Katzka DA, Shah SC, Sauer BG, Aceves SS, Furuta GT, Gonsalves N, Hirano I. Dellon ES, et al. Among authors: shah sc. Am J Gastroenterol. 2025 Jan 1;120(1):31-59. doi: 10.14309/ajg.0000000000003194. Epub 2025 Jan 2. Am J Gastroenterol. 2025. PMID: 39745304

7

Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.

Vakil N, Howden CW, Shah SC, Chen KF, Offman E, Almenoff JS, Sheldon KL. Vakil N, et al. Among authors: shah sc. J Clin Pharmacol. 2025 Jan 2. doi: 10.1002/jcph.6178. Online ahead of print. J Clin Pharmacol. 2025. PMID: 39745109

8

AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review.

Shah SC, Wang AY, Wallace MB, Hwang JH. Shah SC, et al. Gastroenterology. 2024 Dec 23:S0016-5085(24)05663-4. doi: 10.1053/j.gastro.2024.11.001. Online ahead of print. Gastroenterology. 2024. PMID: 39718517

9

Shattering the monolith: burden of gastrointestinal cancer in Asian Americans, Native Hawaiians, and Pacific Islanders in the United States.

Yoon JY, Shah SC, Lin JJ, Kim MK, Itzkowitz SH, Wang CP. Yoon JY, et al. Among authors: shah sc. Lancet Reg Health Am. 2024 Nov 23;41:100954. doi: 10.1016/j.lana.2024.100954. eCollection 2025 Jan. Lancet Reg Health Am. 2024. PMID: 39650260 Free PMC article. Review.

10

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC. Chey WD, et al. Among authors: shah sc. Am J Gastroenterol. 2024 Sep 1;119(9):1730-1753. doi: 10.14309/ajg.0000000000002968. Epub 2024 Sep 4. Am J Gastroenterol. 2024. PMID: 39626064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters